DEVELOPMENT OF AN ALTERNATIVE METHOD FOR TESTING THE IMMUNOGENICITY OF DIPHTHERIA VACCINES

被引:5
|
作者
MANGHI, MA [1 ]
PASETTI, MF [1 ]
BRERO, ML [1 ]
DELUCHI, S [1 ]
DIPAOLA, G [1 ]
MATHET, V [1 ]
ERIKSSON, PV [1 ]
机构
[1] INST NACL MICROBIOL DR CARLOS G MALBRAN,DEPT CONTRALOR,BUENOS AIRES,DF,ARGENTINA
关键词
ANTI-DIPHTHERIA ANTIBODIES; DIPHTHERIA TOROID VACCINE; ELISA;
D O I
10.1016/0264-410X(94)00047-Q
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immunogenicity of the diphtheria component of 73 commercial vaccines fr om Jive different manufacturers was rested by the toxin neutralization test (TNT) and the enzyme-linked immunosorbent assay (ELISA) developed in our laboratory. A comparison of the antibody levels measured by both assays showed a very good correlation (r=0.95, p < 0.001). The results suggest that the proposed ELISA is a reliable, simple and economical alternative to the TNT in guinea pigs. Also, the ELISA was found to measure IgG antibody levels as low as 5.5x10(-5) IU ml(-1). To evaluate the possibility of accelerating the active immunization during the activity test of vaccines an alternative schedule using one single human dose was assayed A very good correlation was observed between the IgG antibody response obtained with this schedule and with the traditional programme. Therefore, the cost and the time required to perform the activity test may be considerably reduced when both the vapid immunization schedule and the ELISA are used.
引用
收藏
页码:597 / 601
页数:5
相关论文
共 50 条
  • [41] Immunogenicity of two diphtheria-tetanus-whole cell pertussis-hepatitis B vaccines in infants A comparative trial
    Kulkarni, Prasad S.
    Sapru, Amita
    Bavdekar, Ashish
    Naik, S. S.
    Patwardhan, Moreshwar
    Barde, Prajakt
    Pandit, Anand N.
    HUMAN VACCINES, 2011, 7 (09): : 941 - 944
  • [42] SAFETY AND IMMUNOGENICITY OF ACELLULAR DIPHTHERIA-TETANUS-PERTUSSIS AND HAEMOPHILUS CONJUGATE VACCINES GIVEN IN COMBINATION OR AT SEPARATE INJECTION SITES
    KOVEL, A
    WALD, ER
    GUERRA, N
    SERDY, C
    MESCHIEVITZ, CK
    JOURNAL OF PEDIATRICS, 1992, 120 (01): : 84 - 87
  • [43] Humanized mice for the development and testing of human vaccines
    Aspord, Caroline
    Yu, Chun I.
    Banchereau, Jacques
    Palucka, A. Karolina
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (07) : 949 - 960
  • [44] THE REDUCTION OF ANIMAL USAGE BY THE APPLICATION OF INDIRECT HEMAGGLUTINATION IN THE POTENCY TESTING OF DIPHTHERIA TOXOID IN COMBINED VACCINES
    MAHESHWARI, SC
    SHARMA, SB
    AHUJA, S
    SAXENA, SN
    JOURNAL OF BIOLOGICAL STANDARDIZATION, 1988, 16 (01): : 9 - 14
  • [45] Effect of DMARDs on the immunogenicity of vaccines
    Yannick van Sleen
    Kornelis S. M. van der Geest
    Anke L. W. Huckriede
    Debbie van Baarle
    Elisabeth Brouwer
    Nature Reviews Rheumatology, 2023, 19 : 560 - 575
  • [46] Challenges of immunogenicity assays for vaccines
    Kostense, Stefan
    Hendriks, Jenny
    BIOANALYSIS, 2012, 4 (04) : 397 - 406
  • [47] Immunogenicity of zona pellucida vaccines
    Ndolo, TM
    Oguna, M
    Bambra, CS
    Dunbar, BS
    Schwoebel, ED
    ZONA PELLUCIDA GLYCOPROTEINS AND IMMUNOCONTRACEPTION, 1996, (50): : 151 - 158
  • [48] Assessment of the protective efficacy of diphtheria vaccines
    Thilo, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1998, 123 (23) : 749 - 749
  • [49] Effect of DMARDs on the immunogenicity of vaccines
    van Sleen, Yannick
    van der Geest, Kornelis S. M.
    Huckriede, Anke L. W.
    van Baarle, Debbie
    Brouwer, Elisabeth
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (09) : 560 - 575
  • [50] ENHANCEMENT OF THE IMMUNOGENICITY OF PEPTIDE VACCINES
    ROWLANDS, DJ
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1989, 17 (05) : 945 - 947